RAC 1.11% $1.83 race oncology ltd

Ann: Race continues Board renewal - appoints new Chair, page-45

  1. 2,621 Posts.
    lightbulb Created with Sketch. 2756
    great overview @EWexplorer

    It’s basically for governance purposes and ensuring everyone plays their relevant roles. Breakdown of governance protocols during a DD can see a deal fall over even if the drug works.

    JC negotiating a deal whilst being impartial to the board and BP at the same time - surely no conflict there?…. I think it’s a balance of tightening governance and planning for a transaction.

    I am sure Danny is contributing to these decisions nicely behind closed doors.

    https://www.aicd.com.au/board-of-directors/roles/chairman/role-of-the-chair.html
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.